An Open-Label Trial of Divalproex in Children and Adolescents with Bipolar Disorder

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 41, Issue 10, 2002, Pages 1224-1230

  Wagner, Karen Dineen ^a,g   Weller, Elizabeth B ^b   Carlson, Gabrielle A ^c   Sachs, Gary ^d   Biederman, Joseph ^d   Frazier, Jean A ^d   Wozniak, Patricia ^e   Tracy, Katherine ^e   Weller, Ronald A ^b   Bowden, Charles ^f  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e ABBOTT LABORATORIES   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Adolescents; Bipolar disorder; Children; Divalproex

Indexed keywords

AMPHETAMINE DERIVATIVE; CLONAZEPAM; HALOPERIDOL; LORAZEPAM; METHYLPHENIDATE; PLACEBO; VALPROATE SEMISODIUM; TRANQUILIZER; VALPROIC ACID;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONDUCT DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; MALE; NAUSEA; OPEN STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHOOL CHILD; SOMNOLENCE; VOMITING; ADULT; CHILD; MULTICENTER STUDY; STATISTICAL MODEL;

ADOLESCENT; ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHILD; FEMALE; HUMANS; LOGISTIC MODELS; MALE; VALPROIC ACID;

EID: 0036783376     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200210000-00012     Document Type: Article

References (27)

1. Ambrosini PJ, Wagner KD, Biederman J et al. (1999), Multicenter open-label sertraline study in adolescent outpatients with major depression. J Am Acad Child Adolesc Psychiatry 38:566-572
2. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
3. Bowden CL, Brugger AM, Swann AC et al. (1994), Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 271:918-924
4. Carlson GA, Rapport MD, Kelly KL, Pataki CS (1992a), The effects of methylphenidate and lithium on attention and activity level. J Am Acad Child Adolesc Psychiatry 31:262-270
5. Carlson GA, Rapport MD, Pataki CS, Kelly KL (1992b), Lithium in hospitalized children at 4 and 8 weeks: mood, behavior and cognitive effects. J Child Psychol Psychiatry 33:411-425
6. Endicott J, Spitzer RL (1978), A diagnostic interview for the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 35:837-844
7. Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976), The Global Assessment Scale: a procedure for measuring overall psychiatric disturbance. Arch Gen Psychiatry 33:766-771
8. Faraone SV, Biederman J, Wozniak J, Mundy E, Mennin D, O'Donnel D (1997), Is comorbidity with ADHD a marker for juvenile-onset mania? J Am Acad Child Adolesc Psychiatry 36:1046-1055
9. Geller B, Cooper T, Sun K et al. (1998), Double-blind, placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependence. J Am Acad Child Adolesc Psychiatry 37:171-178
10. Geller B, Craney J, Bolhofner K, DelBello M, Williams M, Zimmerman B (2001), One-year recovery and relapse rates of children with prepubertal and early adolescent bipolar disorder phenotype. Am J Pychiatry 158:303-304
11. Geller B, Luby J (1997), Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 36:1168-1176
12. Geller B, Zimmerman B, Williams M et al. (2000a), Six-month stability and outcome of a prepubertal and early adolescent bipolar disorder phenotype. J Adolesc Pychopharmacol 10:165-173
13. Geller B, Zimmerman B, Williams M et al. (2000b), Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 10:157-164
14. Guy W, ed (1976), ECDEU Assessment Manual for Psychopharmacology (Publication ADM 76-336). Rockville, MD: US Department of Health, Education, and Welfare
15. Hamilton M (1960), A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
16. Himmelhoch JM, Garfinkel MB (1986), Sources of lithium resistance in mixed mania. Psychopharmacol Bull 22:613-620
17. Kafantaris V, Coetti DJ, Dicker R, Padula G, Kanc JM (2000), Lithium treatment of adolescents with acute mania: a large open study. Presented at Annual Meeting of the American College of Neuropsychopharmacology, San Juan, PR, December 10-14
18. Klein R (1994), Kiddie SADS-Lifetime (K-SADS-L). Columbia University, New York State Psychiatric Institute; available from the author at 1051 Riverside Drive, New York, NY 10032
19. Kowatch RA, Suppes T, Carmody TJ et al. (2000), Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39:713-720
20. Overall JE, Gorham DR (1962), The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812
21. Papatheodorou G, Kutcher SP, Katic M, Szalai JP (1995), The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial. J Clin Psychopharmacol 15:110-116
22. Strober M, DeAntonio M, Schmidy-Lackner S, Freeman R, Lampert C, Diamond J (1998), Early childhood attention deficit hyperactivity disorder predicts poorer response to acute lithium therapy in adolescent mania. J Affect Disord 51:148-151
23. Strober M, Schmidt-Lackner S, Freeman R (1995), Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry 34:724-731
24. US Department of Health and Human Services (1995), Coding Symbols for Thesaurus of Adverse Reaction Terms, 3rd ed. Rockville, MD: Department of Health and Human Services, Food and Drug Administration, Center for Drug and Biologics, Division of Drug and Biological Experience
25. Wagner KD, March J, Cook E, Austin C (2000), Sertraline in the long-term treatment of pediatric OCD. Poster presented at Anxiety Disorders Association of America's 21st National Conference, Atlanta, March 22-25
26. West S, Keck P, McElroy S et al. (1994), Open trial of valproate in the treatment of adolescent mania. J Child Adolesc Psychopharmacol 4:263-267
27. Wozniak J, Biederman J, Mundy E, Mennin D, Faraone SV (1995), A pilot study of childhood-onset mania. J Am Acad Child Adolesc Psychiatry 34:1577-1583